When the U2OS and KHOS/NP osteosarcoma cells were treated with doxorubicin, the expression of cleaved PARP1, cleaved caspase 3, and BAX increased, and the expression of BCL2 decreased (Figure 4). This evidence concerns the gene BCL2 and osteosarcoma.